| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/20/2013 | US8512957 Toxicity typing using liver stem cells |
| 08/20/2013 | US8512953 Diagnostic probe detection system |
| 08/20/2013 | US8512951 Methods for diagnosing stomach cancer using MicroRNAs |
| 08/20/2013 | US8512945 Method of RNA cleavage and recombination |
| 08/20/2013 | US8512712 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 08/20/2013 | US8512710 Class of therapeutic protein based molecules |
| 08/20/2013 | US8512537 Buffers for electrophoresis and use thereof |
| 08/20/2013 | CA2620125C Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 08/20/2013 | CA2560891C Vaccine composition comprising a class ii cmh ligand coupled with an antigen, method for the preparation and the use thereof |
| 08/20/2013 | CA2549932C Production of heterologous glycosylated proteins in bryophyte cells |
| 08/20/2013 | CA2545590C Template fixed beta-hairpin loop mimetics and their use in phage display |
| 08/20/2013 | CA2508660C Antibodies against pd-1 and uses therefor |
| 08/20/2013 | CA2504953C A new target for angiogenesis and anti-angiogenesis therapy |
| 08/20/2013 | CA2499390C Kits and methods for assessing skin health |
| 08/20/2013 | CA2492932C Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 08/20/2013 | CA2492333C Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 08/20/2013 | CA2488558C Prevention and reduction of blood loss |
| 08/20/2013 | CA2477794C System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 08/20/2013 | CA2452417C Compositions comprising the biologicially active peptide ysl |
| 08/20/2013 | CA2449661C Method for obtaining a monocotyledon plant containing a gene of interest free of foreign ancillary sequence |
| 08/20/2013 | CA2445349C Anti-cd40 monoclonal antibody |
| 08/20/2013 | CA2440358C Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 08/20/2013 | CA2407301C Hsp60 sequence from piscirickettsia salmonis |
| 08/15/2013 | WO2013120037A1 Dna assimilation |
| 08/15/2013 | WO2013120018A1 Methods and compositions for screening and treating developmental disorders |
| 08/15/2013 | WO2013120003A1 Modulation of rna by repeat targeting |
| 08/15/2013 | WO2013119979A1 Methods and compositions for modulating factor vii expression |
| 08/15/2013 | WO2013119962A1 Pericarp dna extraction and matrilineage determination |
| 08/15/2013 | WO2013119948A1 Rna-mediated gene assembly from dna oligonucleotides |
| 08/15/2013 | WO2013119947A1 Pepmixes to generate multiviral ctls with broad specificity |
| 08/15/2013 | WO2013119923A1 Different states of cancer stem cells |
| 08/15/2013 | WO2013119903A1 Fusion proteins comprising immunoglobulin constant domain-derived scaffolds |
| 08/15/2013 | WO2013119827A1 Direct rna capture with molecular inversion probes |
| 08/15/2013 | WO2013119809A1 Biomarkers for hematologic malignacies |
| 08/15/2013 | WO2013119784A1 Methods of sequencing nucleic acids using nanopores and active kinetic proofreading |
| 08/15/2013 | WO2013119690A1 Nucleic acid ligation method |
| 08/15/2013 | WO2013119684A1 Methods and materials for identifying mammals having prostate cancer |
| 08/15/2013 | WO2013119683A1 Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses |
| 08/15/2013 | WO2013119678A1 Lkb1/stk11 deletion in melanoma and related methods |
| 08/15/2013 | WO2013119644A1 Production of beta-phellandrene using genetically engineered cyanobacteria |
| 08/15/2013 | WO2013119541A1 Tobacco having altered amounts of environmental contaminants and methods for producing such lines |
| 08/15/2013 | WO2013119371A2 Mini-intronic plasmid vectors |
| 08/15/2013 | WO2013119331A1 Animal models of atherosclerosis |
| 08/15/2013 | WO2013118967A1 Dna aptamer specifically binding to invasion plasmid antigen h protein of shigella sonnei, and use thereof |
| 08/15/2013 | WO2013118165A1 Pharmaceutical agents fused with atf for improved bioavailability |
| 08/15/2013 | WO2013117912A1 Sheep nematode vaccine |
| 08/15/2013 | WO2013117910A1 Pest and pathogen control |
| 08/15/2013 | WO2013117713A1 Reversal of senescence |
| 08/15/2013 | WO2013117591A1 Method for linking and characterising linked nucleic acids, e.g. antibody encoding nucleic acids, in a composition |
| 08/15/2013 | WO2013117348A1 Agonists and antagonists of toll-like receptor (tlr) 13 |
| 08/15/2013 | WO2013116965A1 Combined antigen and dna vaccine for preventing and treating rsv infection |
| 08/15/2013 | WO2013092965A3 Bacteria with reconstructed transcriptional units and the uses thereof |
| 08/15/2013 | WO2013092275A3 Genes to enhance the defense against pathogens in plants |
| 08/15/2013 | WO2013091661A3 Proteolytic resistant protein affinity tag |
| 08/15/2013 | WO2013082515A3 Nucleic acid aptamers directed to surface receptors and methods of use |
| 08/15/2013 | WO2013074814A3 Morpholinos, morpholino upregulating, and associated methods |
| 08/15/2013 | WO2013067259A3 Regulatory nucleic acids and methods of use |
| 08/15/2013 | WO2013066438A3 Evaluation and improvement of nuclease cleavage specificity |
| 08/15/2013 | WO2013061328A3 Methods of treating cancer |
| 08/15/2013 | WO2013006486A9 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 08/15/2013 | US20130212748 Secreted Insecticidal Protein and Gene Compositions From Bacillus Thuringiensis and Uses Therefor |
| 08/15/2013 | US20130212747 HERBICIDE TOLERANT COTTON EVENT pDAB4468.19.10.3 |
| 08/15/2013 | US20130212743 Method for increasing plant biomass by controlling active cytokinin expression level |
| 08/15/2013 | US20130212742 Laticiferous tissue-specific srpp promoter from hevea brasiliensis and uses thereof |
| 08/15/2013 | US20130212741 MOLECULAR CLONING OF BROWN-MIDRIB2 (bm2) GENE |
| 08/15/2013 | US20130212740 Fucosyl transferase gene |
| 08/15/2013 | US20130212739 Process for transfecting plants |
| 08/15/2013 | US20130212738 Composition for phytochelatin transport |
| 08/15/2013 | US20130212737 Glyphosate resistant plants and associated methods |
| 08/15/2013 | US20130212736 Enzyme directed oil biosynthesis in microalgae |
| 08/15/2013 | US20130212735 Modulating the level of components within plants |
| 08/15/2013 | US20130212733 Soybean variety dll0838 |
| 08/15/2013 | US20130212732 Soybean variety dll1143 |
| 08/15/2013 | US20130212731 Soybean variety dll1141 |
| 08/15/2013 | US20130212730 Soybean variety dll1290 |
| 08/15/2013 | US20130212729 Plants and seeds of common wheat cultivar bz6w07-458 |
| 08/15/2013 | US20130212728 Plants and seeds of common wheat cultivar bz6w07-427 |
| 08/15/2013 | US20130212727 Hybrid canola quality brassica juncea |
| 08/15/2013 | US20130212725 Fusion proteins comprising a dna-binding domain of a tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| 08/15/2013 | US20130212723 Transgenic animals with customizable traits |
| 08/15/2013 | US20130212722 Transgenic animals with customizable traits |
| 08/15/2013 | US20130212717 Method for producing pentameric crp, pentameric crp-producing transgenic silkworm and method for constructing same, dna encoding canine monomeric crp and expression vector containing the dna |
| 08/15/2013 | US20130211170 Isopropyl alcohol-producing bacterium having improved productivity by gntr destruction |
| 08/15/2013 | US20130211064 Tetrahydropyran nucleic acid analogs |
| 08/15/2013 | US20130211063 MODIFIED iRNA AGENTS |
| 08/15/2013 | US20130210902 Modified human u1snrna molecule, a gene encoding for the modified human u1snrna molecule, an expression vector including the gene, and the use thereof in gene therapy |
| 08/15/2013 | US20130210898 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same |
| 08/15/2013 | US20130210897 Mini-intronic plasmid vectors |
| 08/15/2013 | US20130210895 rAAV-Guanylate Cyclase Compositions and Methods for Treating Lebers Congenital Amaurosis-1 (LCA1) |
| 08/15/2013 | US20130210894 Application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas |
| 08/15/2013 | US20130210723 Use of the Insulin-Like-Growth Factor 1 Splice Variant MGF for the Prevention of Myocardial Damage |
| 08/15/2013 | US20130210681 Direct Cloning |
| 08/15/2013 | US20130210680 Systems and methods for amplification and phage display |
| 08/15/2013 | US20130210676 siRNA Targeting Myeloid Differentiation Primary Response Gene (88) (MYD88) |
| 08/15/2013 | US20130210674 Whole genome expression analysis system |
| 08/15/2013 | US20130210673 Polypeptide Display Libraries and Methods of Making and Using Thereof |
| 08/15/2013 | US20130210665 Method and kit for the diagnosis and/or prognosis of tolerance in liver transplantation |
| 08/15/2013 | US20130210659 Molecular diagnostic screening assay |
| 08/15/2013 | US20130210656 Late-pcr |
| 08/15/2013 | US20130210639 Microfluidic devices |